Adrenone; Stryphnon; Adrenon; Chemosan; Haemodan; Kephrine; Ketogaze; Remestyp; Stryphnone; Stypnon; Styphnone; Stypnone; 1-(3,4-Dihydroxyphenyl)-2-(methylamino)ethanone; 4-Methylaminoacetocatechol; Methaminoacetocatechol; 4-Methylaminoacetopyrocatechol; 1-(3,4-DIHYDROXY-PHENYL)-2-METHYLAMINO-ETHANONE; 3',4'-Dihydroxy-2-(methylamino)acetophenone; Ethanone, 1-(3,4-dihydroxyphenyl)-2-(methylamino)-; UNII-EGU41QL329; U 2134; NSC 243611; component of Epitrate; 1-(3,4-dihydroxyphenyl)-2-(methylamino)ethan-1-one; 3,4-Dihydroxy-alpha-methylaminoacetophenone; MLS001032115; EGU41QL329; NSC243611; ACETOPHENONE, 3',4'-DIHYDROXY-2-(METHYLAMINO)-; NCGC00160472-01; Adrenonum; SMR000718615; 3,4-Dihydroxy-.alpha.-methylaminoacetophenone; DSSTox_CID_28636; DSSTox_RID_82906; DSSTox_GSID_48710; 1-[3,4-bis(oxidanyl)phenyl]-2-(methylamino)ethanone; Adrenalona; Adrenalonum; Adrenalone [USAN:INN]; Adrenalonum [INN-Latin]; Adrenalona [INN-Spanish]; EINECS 202-756-9; adrenalon; BRN 2366101; Adrenalone (USAN/INN); cid_7436; WLN: QR BQ DV1M1; SCHEMBL123124; CHEMBL2103996; DTXSID5048710; BDBM94970; CTK5I0428; PZMVOUYYNKPMSI-UHFFFAOYSA-; ALBB-025687; Tox21_113112; SBB072639; STL412109; ZINC34781660; AKOS004119969; Tox21_113112_1; AB06968; DB13394; MCULE-5219258762; NE62917; NSC-243611; NCGC00160472-02; AC-10027; SC-81818; AB0017792; DB-057784; Acetophenone,4'-dihydroxy-2-(methylamino)-; FT-0631521; ST45028726; Ethanone,4-dihydroxyphenyl)-2-(methylamino)-; 3', 4'-Dihydroxy-2-(methylamino)acetophenone; 3, 4-Dihydroxy-.alpha.-methylaminoacetophenone; D02774; ETHYL(2-METHOXY-BIPHENYL-4-YL)-ACETATE; U-2134; AB01563148_01; AB01563148_02; A846029; Acetophenone, 3', 4'-dihydroxy-2-(methylamino)-; 1-(3,4-Dihydroxyphenyl)-2-(methylamino)ethanone #; J-519543; Q2186476; Ethanone, 1-(3, 4-dihydroxyphenyl)-2-(methylamino)-; 1-(3,4-dihydroxyphenyl)-2-methylaminoethanone hydrochloride